Tag: vaccine
AstraZeneca takes COVID-19 vaccine to China with BioKangtai deal for 200M-dose...
We pointed out last week that China was a notable missing element in AstraZeneca’s COVID-19 vaccine strategy, despite being the drugmaker’s second-largest market. That...
Novavax, Fujifilm lock up supply for late-stage COVID-19 vaccine trial
Maryland biotech Novavax scored a big leg up in its hunt for a COVID-19 vaccine with a major infusion from the Trump administration this...
Niche vaccine player Valneva, UK tie up in coronavirus R&D and...
COVID-19 frontrunners have been inking deals with governments and others to supply vaccines if their programs succeed, and now niche player Valneva is getting involved.
Valneva on Monday...
Moderna’s COVID-19 vaccine could cruise to $5B in sales—or more, analysts...
Moderna has never scored a commercial approval for any of its drugs or vaccines, but analysts with Jefferies think the company has a winner in...
J&J scores Ebola vaccine approval in Europe. Can the platform win...
Johnson & Johnson has spent years building up its vaccine capabilities, and amid the coronavirus pandemic, its work in the field has taken on new...
Pfizer, BioNTech coronavirus vaccine candidate gins up antibodies in early trial
With the eyes of the world turned on the global COVID-19 vaccine race, Pfizer and its partner BioNTech posted early positive data from one of their...
Novavax hires new manufacturing chief to take COVID-19, flu vaccine hopefuls...
With its COVID-19 vaccine hopeful cycling through clinical trials, shot maker Novavax is working to flesh out its executive team to help lead the...
AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine...
AstraZeneca has picked up manufacturing partners at a rapid clip with a goal to produce 2 billion doses per year of the University of...
FiercePharmaPolitics—FDA could approve ‘at least one’ COVID-19 vaccine before election: analyst
About six months into the pandemic and about 130 days until the U.S. presidential election, COVID-19 vaccines are moving ahead at record speeds. Now, a...
Vaccine heroes? COVID-19 pitfalls, pricing put pharma on the spot
Pharma is looking to reset its image with COVID-19 vaccines and treatments, but landmines loom—with pricing likely the biggest.
The halo from pharma’s rapid response...
